• Record Q2 2026 revenue of approximately $19.4 million, up approximately 31.5% year-over-year from $14.75 million in Q2 2025
  • Record first-half 2026 revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 2025
  • 3,640,000 shares repurchased as of July 6, 2026 for approximately $700,000 under the Company's $5 million buyback program, with open market purchases ongoing

     

CHICAGO, July 07, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today provided a business update on its second quarter and first-half revenue performance and share repurchase activity.

Record Q2 and H1 2026 Revenue: Based on preliminary results, the Company expects to report second-quarter 2026 revenue of approximately $19.4 million, up approximately 31.5% from $14.75 million in Q2 2025, and first-half revenue of approximately $37.3 million, up approximately 31% from $28.46 million in H1 2025 — both the highest in the Company's history. Full financial results and commentary will be provided in the Company's Q2 2026 earnings release.

Ongoing Share Repurchases: Cosmos Health continues to repurchase shares in the open market under its previously announced share repurchase program of up to $5 million. As of July 6, 2026, the Company had repurchased 3,640,000 shares in multiple transactions for approximately $700,000, and it intends to continue making open market purchases, subject to market conditions, under the program, which expires on December 31, 2026, and may be renewed at the Company's sole discretion.